{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:07:16Z","timestamp":1789992436760,"version":"4.0.1"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T00:00:00Z","timestamp":1551744000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s00415-019-09263-7","type":"journal-article","created":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T06:38:59Z","timestamp":1551767939000},"page":"1340-1350","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Non-motor symptoms in Huntington\u2019s disease: a comparative study with Parkinson\u2019s disease"],"prefix":"10.1007","volume":"266","author":[{"given":"Tatiana","family":"Aldaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Nigro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almudena","family":"S\u00e1nchez-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celia","family":"Painous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Llu\u00eds","family":"Planellas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Santacruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"C\u00e1mara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaroslau","family":"Compta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesc","family":"Valldeoriola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J.","family":"Mart\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0986-1291","authenticated-orcid":false,"given":"Esteban","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,5]]},"reference":[{"key":"9263_CR1","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/nrg1686","volume":"6","author":"GP Bates","year":"2005","unstructured":"Bates GP (2005) The molecular genetics of Huntington disease\u2014a history. Nat Rev Genet 6:766\u2013773","journal-title":"Nat Rev Genet"},{"key":"9263_CR2","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","volume":"369","author":"FO Walker","year":"2007","unstructured":"Walker FO (2007) Huntington\u2019s disease. Lancet 369:218\u2013228","journal-title":"Lancet"},{"key":"9263_CR3","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1126\/science.3155875","volume":"227","author":"GA Graveland","year":"1985","unstructured":"Graveland GA, Williams RS, DiFiglia M (1985) Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington\u2019s disease. Science 227:770\u2013773","journal-title":"Science"},{"key":"9263_CR4","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1111\/bpa.12426","volume":"26","author":"U R\u00fcb","year":"2016","unstructured":"R\u00fcb U, Seidel K, Heinsen H, Vonsattel JP, den Dunnen WF, Korf HW (2016) Huntington\u2019s disease (HD): the neuropathology of a multisystem neurodegenerative disorder of the human brain. Brain Pathol 26:726\u2013740","journal-title":"Brain Pathol"},{"key":"9263_CR5","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1136\/jnnp.72.6.726","volume":"72","author":"J Andrich","year":"2002","unstructured":"Andrich J, Schmitz T, Saft C, Postert T, Kraus P, Epplen JT, Przuntek H, Agelink MW (2002) Autonomic nervous system function in Huntington\u2019s disease. J Neurol Neurosurg Psychiatry 72:726\u2013731","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9263_CR6","doi-asserted-by":"publisher","first-page":"e1058464","DOI":"10.1080\/21675511.2015.1058464","volume":"3","author":"M Mielcarek","year":"2015","unstructured":"Mielcarek M (2015) Huntington\u2019s disease is a multi-system disorder. Rare Dis 3:e1058464","journal-title":"Rare Dis"},{"key":"9263_CR7","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/mdc3.12596","volume":"5","author":"CD Stephen","year":"2018","unstructured":"Stephen CD, Hung J, Schifitto G, Hersch SM, Rosas HD (2018) Electrocardiogram abnormalities suggest aberrant cardiac conduction in Huntington\u2019s disease. Mov Disord Clin Pract 5:306\u2013311","journal-title":"Mov Disord Clin Pract"},{"key":"9263_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2011.05.006","volume":"44","author":"JMM Burg Van der","year":"2011","unstructured":"Van der Burg JMM, Winqvist A, Aziz NA, Maat-Schieman MLC, Roos RAC, Bates GP, Brundin P, Bj\u00f6rkqvist M, Wierup N (2011) Gastrointestinal dysfunction contributes to weight loss in Huntington\u2019s disease mice. Neurobiol Dis 44:1\u20138","journal-title":"Neurobiol Dis"},{"key":"9263_CR9","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/S1474-4422(15)00177-5","volume":"14","author":"JB Carroll","year":"2015","unstructured":"Carroll JB, Bates GP, Steffan J, Saft C, Tabrizi SJ (2015) Treating the whole body in Huntington\u2019s disease. Lancet Neurol 14:1135\u20131142","journal-title":"Lancet Neurol"},{"key":"9263_CR10","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1212\/WNL.0b013e318282514e","volume":"80","author":"SH Stuwe","year":"2013","unstructured":"Stuwe SH, Goetze O, Lukas C, Klotz P, Hoffmann R, Banasch M, Orth M, Schmidt WE, Gold R, Saft C (2013) Hepatic mitochondrial dysfunction in manifest and premanifest Huntington disease. Neurology 80:743\u2013746","journal-title":"Neurology"},{"key":"9263_CR11","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.parkreldis.2014.12.031","volume":"21","author":"KR Chaudhuri","year":"2015","unstructured":"Chaudhuri KR, Sauerbier A, Rojo JM, Sethi K, Schapira AHV, Brown RG, Antonini A, Stocchi F, Odin P, Bhattacharya K, Tsuboi Y, Abe K, Rizos A, Rodriguez-Blazquez C, Martinez-Martin P (2015) The burden of non-motor symptoms in Parkinson\u2019s disease using a self-completed non-motor questionnaire: a simple grading system. Park Relat Disord 21:287\u2013291","journal-title":"Park Relat Disord"},{"key":"9263_CR12","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1002\/mds.20844","volume":"21","author":"KR Chaudhuri","year":"2006","unstructured":"Chaudhuri KR, Martinez-Martin P, Schapira AHV, Stocchi F, Sethi K, Odin P, Brown RG, Koller W, Barone P, MacPhee G, Kelly L, Rabey M, MacMahon D, Thomas S, Ondo W, Rye D, Forbes A, Tluk S, Dhawan V, Bowron A, Williams AJ, Olanow CW (2006) International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson\u2019s disease: the NMSQuest study. Mov Disord 21:916\u2013923","journal-title":"Mov Disord"},{"key":"9263_CR13","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/mds.870110204","volume":"11","author":"Huntington Study Group","year":"1996","unstructured":"Huntington Study Group (1996) Unified Huntington\u2019s Disease Rating Scale: reliability and consistency. Mov Disord 11:136\u2013142","journal-title":"Mov Disord"},{"key":"9263_CR14","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30:1591\u20131601","journal-title":"Mov Disord"},{"key":"9263_CR15","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, van Hilten JJ, LaPelle N, Agarwal P, Athar S, Bordelan Y, Bronte-Stewart HM, Camicioli R, Chou K, Cole W, Dalvi A, Delgado H, Diamond A, Dick JP, Duda J, Elble RJ, Evans C, Evidente VG, Fernandez HH, Fox S, Friedman JH, Fross RD, Gallagher D, Goetz CG, Hall D, Hermanowicz N, Hinson V, Horn S, Hurtig H, Kang UJ, Kleiner-Fisman G, Klepitskaya O, Kompoliti K, Lai EC, Leehey ML, Leroi I, Lyons KE, McClain T, Metzer SW, Miyasaki J, Morgan JC, Nance M, Nemeth J, Pahwa R, Parashos SA, Schneider JSJS, Schrag A, Sethi K, Shulman LM, Siderowf A, Silverdale M, Simuni T, Stacy M, Stern MB, Stewart RM, Sullivan K, Swope DM, Wadia PM, Walker RW, Walker R, Weiner WJ, Wiener J, Wilkinson J, Wojcieszek JM, Wolfrath S, Wooten F, Wu A, Zesiewicz TA, Zweig RM (2008) Movement Disorder Society-Sponsored Revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results. Mov Disord 23:2129\u20132170. https:\/\/doi.org\/10.1002\/mds.22340","journal-title":"Mov Disord"},{"key":"9263_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1212\/WNL.29.1.1","volume":"29","author":"I Shoulson","year":"1979","unstructured":"Shoulson I, Fahn S (1979) Huntington disease: clinical care and evaluation. Neurology 29:1\u20131","journal-title":"Neurology"},{"key":"9263_CR17","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S1474-4422(13)70088-7","volume":"12","author":"SJ Tabrizi","year":"2013","unstructured":"Tabrizi SJ, Scahill RI, Owen G, Durr A, Leavitt BR, Roos RA, Borowsky B, Landwehrmeyer B, Frost C, Johnson H, Craufurd D, Reilmann R, Stout JC, Langbehn DR (2013) Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington\u2019s disease in the TRACK-HD study: analysis of 36-month observational data. Lancet Neurol 12:637\u2013649","journal-title":"Lancet Neurol"},{"key":"9263_CR18","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1002\/mds.21586","volume":"22","author":"P Martinez-Martin","year":"2007","unstructured":"Martinez-Martin P, Schapira AHV, Stocchi F, Sethi K, Odin P, MacPhee G, Brown RG, Naidu Y, Clayton L, Abe K, Tsuboi Y, MacMahon D, Barone P, Rabey M, Bonuccelli U, Forbes A, Breen K, Tluk S, Olanow CW, Thomas S, Rye D, Hand A, Williams AJ, Ondo W, Chaudhuri KR (2007) Prevalence of nonmotor symptoms in Parkinson\u2019s disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients. Mov Disord 22:1623\u20131629","journal-title":"Mov Disord"},{"key":"9263_CR19","doi-asserted-by":"publisher","first-page":"18","DOI":"10.12968\/hmed.2014.75.1.18","volume":"75","author":"A Sauerbier","year":"2014","unstructured":"Sauerbier A, Chaudhuri KR (2014) Non-motor symptoms: the core of multi-morbid Parkinson\u2019s disease. Br J Hosp Med 75:18\u201324","journal-title":"Br J Hosp Med"},{"key":"9263_CR20","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1515\/REVNEURO.2007.18.3-4.223","volume":"18","author":"NA Aziz","year":"2007","unstructured":"Aziz NA, Swaab DF, Pijl H, Roos RAC (2007) Hypothalamic dysfunction and neuroendocrine and metabolic alterations in Huntington\u2019s Disease: clinical consequences and therapeutic implications. Rev Neurosci 18:223\u2013252","journal-title":"Rev Neurosci"},{"issue":"Suppl 1","key":"9263_CR21","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1468-1331.2008.02056.x","volume":"15","author":"W Poewe","year":"2008","unstructured":"Poewe W (2008) Non-motor symptoms in Parkinson\u2019s disease. Eur J Neurol 15(Suppl 1):14\u201320","journal-title":"Eur J Neurol"},{"key":"9263_CR22","doi-asserted-by":"publisher","first-page":"RRN1293","DOI":"10.1371\/currents.RRN1293","volume":"4","author":"A-W Heemskerk","year":"2012","unstructured":"Heemskerk A-W, Roos RAC (2012) Aspiration pneumonia and death in Huntington\u2019s disease. PLoS Curr 4:RRN1293","journal-title":"PLoS Curr"},{"key":"9263_CR23","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s00455-010-9302-4","volume":"26","author":"A-W Heemskerk","year":"2011","unstructured":"Heemskerk A-W, Roos RAC (2011) Dysphagia in Huntington\u2019s disease: a review. Dysphagia 26:62\u201366","journal-title":"Dysphagia"},{"key":"9263_CR24","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/S1474-4422(15)00007-1","volume":"14","author":"A Fasano","year":"2015","unstructured":"Fasano A, Visanji NP, Liu LWC, Lang AE, Pfeiffer RF (2015) Gastrointestinal dysfunction in Parkinson\u2019s disease. Lancet Neurol 14:625\u2013639","journal-title":"Lancet Neurol"},{"key":"9263_CR25","doi-asserted-by":"publisher","first-page":"e8025","DOI":"10.1371\/journal.pone.0008025","volume":"4","author":"H Moffitt","year":"2009","unstructured":"Moffitt H, McPhail GD, Woodman B, Hobbs C, Bates GP (2009) Formation of polyglutamine inclusions in a wide range of non-CNS tissues in the HdhQ150 knock-in mouse model of Huntington\u2019s disease. PLoS One 4:e8025","journal-title":"PLoS One"},{"key":"9263_CR26","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/00002826-200211000-00003","volume":"25","author":"WG Ondo","year":"2002","unstructured":"Ondo WG, Tintner R, Thomas M, Jankovic J (2002) Tetrabenazine treatment for Huntington\u2019s disease-associated chorea. Clin Neuropharmacol 25:300\u2013302","journal-title":"Clin Neuropharmacol"},{"key":"9263_CR27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1471-230X-11-17","volume":"11","author":"M Hert De","year":"2011","unstructured":"De Hert M, Dockx L, Bernagie C, Peuskens B, Sweers K, Leucht S, Tack J, Van de Straete S, Wampers M, Peuskens J (2011) Prevalence and severity of antipsychotic related constipation in patients with schizophrenia: a retrospective descriptive study. BMC Gastroenterol 11:17","journal-title":"BMC Gastroenterol"},{"key":"9263_CR28","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/bs.irn.2017.06.003","volume":"134","author":"F Stocchi","year":"2017","unstructured":"Stocchi F, Torti M (2017) Constipation in Parkinson\u2019s disease. Int Rev Neurobiol 134:811\u2013826","journal-title":"Int Rev Neurobiol"},{"key":"9263_CR29","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1007\/s00702-018-1869-1","volume":"125","author":"S Perez-Lloret","year":"2018","unstructured":"Perez-Lloret S, Rascol O (2018) Efficacy and safety of amantadine for the treatment of L-DOPA-induced dyskinesia. J Neural Transm 125:1237\u20131250","journal-title":"J Neural Transm"},{"key":"9263_CR30","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1017\/S1355617700000278","volume":"1","author":"S Nordin","year":"1995","unstructured":"Nordin S, Paulsen JS, Murphy C (1995) Sensory- and memory-mediated olfactory dysfunction in Huntington\u2019s disease. J Int Neuropsychol Soc 1:281\u2013290","journal-title":"J Int Neuropsychol Soc"},{"key":"9263_CR31","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/WNR.0b013e3280102302","volume":"18","author":"FA Barrios","year":"2007","unstructured":"Barrios FA, Gonzalez L, Favila R, Alonso ME, Salgado PM, Diaz R, Fernandez-Ruiz J (2007) Olfaction and neurodegeneration in HD. Neuroreport 18:73\u201376","journal-title":"Neuroreport"},{"key":"9263_CR32","doi-asserted-by":"publisher","first-page":"e0116069","DOI":"10.1371\/journal.pone.0116069","volume":"10","author":"M Kandasamy","year":"2015","unstructured":"Kandasamy M, Rosskopf M, Wagner K, Klein B, Couillard-Despres S, Reitsamer HA, Stephan M, Nguyen HP, Riess O, Bogdahn U, Winkler J, von Horsten S, Aigner L (2015) Reduction in subventricular zone-derived olfactory bulb neurogenesis in a rat model of Huntington\u2019s disease is accompanied by striatal invasion of neuroblasts. PLoS One 10:e0116069","journal-title":"PLoS One"},{"key":"9263_CR33","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1111\/j.1468-1331.2010.02973.x","volume":"17","author":"NA Aziz","year":"2010","unstructured":"Aziz NA, Anguelova GV, Marinus J, Van Dijk JG, Roos RAC (2010) Autonomic symptoms in patients and pre-manifest mutation carriers of Huntington\u2019s disease. Eur J Neurol 17:1068\u20131074","journal-title":"Eur J Neurol"},{"key":"9263_CR34","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1007\/s00415-014-7494-5","volume":"261","author":"M Kolenc","year":"2014","unstructured":"Kolenc M, Moharic M, Kobal J, Podnar S (2014) Bladder dysfunction in presymptomatic gene carriers and patients with Huntington\u2019s disease. J Neurol 261:2360\u20132369","journal-title":"J Neurol"},{"key":"9263_CR35","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1179\/1743132813Y.0000000264","volume":"36","author":"AQ Rana","year":"2014","unstructured":"Rana AQ, Vaid H, Akhter MR, Awan NY, Fattah A, Cader MH, Hafez K, Rana MA, Yousuf MS (2014) Prevalence of nocturia in Parkinson\u2019s disease patients from various ethnicities. Neurol Res 36:234\u2013238","journal-title":"Neurol Res"},{"key":"9263_CR36","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jsmc.2017.09.010","volume":"13","author":"CP Vaughan","year":"2018","unstructured":"Vaughan CP, Bliwise DL (2018) Sleep and nocturia in older adults. Sleep Med Clin 13:107\u2013116","journal-title":"Sleep Med Clin"},{"key":"9263_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2741\/S355","volume":"5","author":"EM Dumas","year":"2013","unstructured":"Dumas EM, van den Bogaard SJA, Middelkoop HAM, Roos RAC (2013) A review of cognition in Huntington\u2019s disease. Front Biosci (Schol Ed) 5:1\u201318","journal-title":"Front Biosci (Schol Ed)"},{"key":"9263_CR38","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1016\/j.neuropsychologia.2006.01.015","volume":"44","author":"A Montoya","year":"2006","unstructured":"Montoya A, Pelletier M, Menear M, Duplessis E (2006) Episodic memory impairment in Huntington\u2019 s disease: a meta-analysis. Neuropsychologia 44:1984\u20131994","journal-title":"Neuropsychologia"},{"key":"9263_CR39","first-page":"RRN1184","volume":"2","author":"M Orth","year":"2010","unstructured":"Orth M, Handley OJ, Schwenke C, Dunnett SB, Craufurd D, Ho AK, Wild E, Tabrizi SJ, Landwehrmeyer GB (2010) Observing Huntington\u2019s disease: the European Huntington\u2019s Disease Network\u2019s REGISTRY. PLoS Curr 2:RRN1184","journal-title":"PLoS Curr"},{"key":"9263_CR40","first-page":"639","volume":"29","author":"C Tannenbaum","year":"2012","unstructured":"Tannenbaum C, Paquette A, Hilmer S, Holroyd-Leduc J, Carnahan R (2012) A systematic review of amnestic and non-amnestic mild cognitive impairment induced by anticholinergic, antihistamine, GABAergic and opioid drugs. Drugs Aging 29:639\u2013658","journal-title":"Drugs Aging"},{"key":"9263_CR41","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1176\/jnp.2009.21.3.266","volume":"21","author":"P Naarding","year":"2009","unstructured":"Naarding P, Janzing JGE, Eling P, van der Werf S, Kremer B (2009) Apathy is not depression in Huntington\u2019s disease. J Neuropsychiatry Clin Neurosci 21:266\u2013270","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"9263_CR42","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1176\/jnp.23.4.jnp434","volume":"23","author":"N Reedeker","year":"2011","unstructured":"Reedeker N, Bouwens JA, van Duijn E, Giltay EJ, Roos RAC, van der Mast RC (2011) Incidence, course, and predictors of apathy in Huntington\u2019s disease: a two-year prospective study. J Neuropsychiatry Clin Neurosci 23:434\u2013441","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"9263_CR43","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000343210","volume":"13","author":"E Duijn van","year":"2014","unstructured":"van Duijn E, Reedeker N, Giltay EJ, Eindhoven D, Roos RAC, van der Mast RC (2014) Course of irritability, depression and apathy in Huntington\u2019s disease in relation to motor symptoms during a two-year follow-up period. Neurodegener Dis 13:9\u201316","journal-title":"Neurodegener Dis"},{"key":"9263_CR44","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1176\/jnp.2010.22.3.287","volume":"22","author":"E Duijn van","year":"2010","unstructured":"van Duijn E, Reedeker N, Giltay EJ, Roos RAC, van der Mast RC (2010) Correlates of apathy in Huntington\u2019s disease. J Neuropsychiatry Clin Neurosci 22:287\u2013294","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"7","key":"9263_CR45","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1002\/mds.27395","volume":"33","author":"S Martinez-Horta","year":"2018","unstructured":"Martinez-Horta S, Perez-Perez J, Sampedro F, Pagonabarraga J, Horta-Barba A, Carceller-Sindreu M, Gomez-Anson B, Lozano-Martinez GA, Lopez-Mora DA, Camacho V, Fernandez-Leon A, Carrio I, Kulisevsky J (2018) Structural and metabolic brain correlates of apathy in Huntington\u2019s disease. Mov Disord 33(7):1151\u20131159","journal-title":"Mov Disord"},{"key":"9263_CR46","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1159\/000481981","volume":"79","author":"M Sousa","year":"2018","unstructured":"Sousa M, Moreira F, Jesus-Ribeiro J, Marques I, Cunha F, Can\u00e1rio N, Freire A, Janu\u00e1rio C (2018) Apathy profile in Parkinson\u2019s and Huntington\u2019s disease: a comparative cross-sectional study. Eur Neurol 79:13\u201320","journal-title":"Eur Neurol"},{"key":"9263_CR47","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1002\/mds.22843","volume":"24","author":"K Dujardin","year":"2009","unstructured":"Dujardin K, Sockeel P, Delliaux M, Destee A, Defebvre L (2009) Apathy may herald cognitive decline and dementia in Parkinson\u2019s disease. Mov Disord 24:2391\u20132397","journal-title":"Mov Disord"},{"key":"9263_CR48","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1007\/s11940-011-0140-y","volume":"13","author":"A Krishnamoorthy","year":"2011","unstructured":"Krishnamoorthy A, Craufurd D (2011) Treatment of apathy in Huntington\u2019s disease and other movement disorders. Curr Treat Options Neurol 13:508\u2013519","journal-title":"Curr Treat Options Neurol"},{"key":"9263_CR49","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1212\/WNL.0000000000000050","volume":"82","author":"F Ory-Magne","year":"2014","unstructured":"Ory-Magne F, Corvol J-C, Azulay J-P, Bonnet A-M, Brefel-Courbon C, Damier P, Dellapina E, Destee A, Durif F, Galitzky M, Lebouvier T, Meissner W, Thalamas C, Tison F, Salis A, Sommet A, Viallet F, Vidailhet M, Rascol O (2014) Withdrawing amantadine in dyskinetic patients with Parkinson disease: the AMANDYSK trial. Neurology 82:300\u2013307","journal-title":"Neurology"},{"key":"9263_CR50","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1176\/jnp.2007.19.4.441","volume":"19","author":"E Duijn van","year":"2007","unstructured":"van Duijn E, Kingma EM, van der Mast RC (2007) Psychopathology in verified Huntington\u2019s disease gene carriers. J Neuropsychiatry Clin Neurosci 19:441\u2013448","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"9263_CR51","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3390\/brainsci7060067","volume":"7","author":"RA Paoli","year":"2017","unstructured":"Paoli RA, Botturi A, Ciammola A, Silani V, Prunas C, Lucchiari C, Zugno E, Caletti E (2017) Neuropsychiatric burden in Huntington\u2019s disease. Brain Sci 7:67","journal-title":"Brain Sci"},{"key":"9263_CR52","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1176\/jnp.14.1.37","volume":"14","author":"JC Thompson","year":"2002","unstructured":"Thompson JC, Snowden JS, Craufurd D, Neary D (2002) Behavior in Huntington\u2019s disease: dissociating cognition-based and mood-based changes. J Neuropsychiatry Clin Neurosci 14:37\u201343","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"9263_CR53","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1176\/jnp.17.4.496","volume":"17","author":"JS Paulsen","year":"2005","unstructured":"Paulsen JS, Nehl C, Hoth KF, Kanz JE, Benjamin M, Conybeare R, McDowell B, Turner B (2005) Depression and stages of Huntington\u2019s disease. J Neuropsychiatry Clin Neurosci 17:496\u2013502","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"9263_CR54","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1176\/appi.ajp.162.4.725","volume":"162","author":"JS Paulsen","year":"2005","unstructured":"Paulsen JS, Hoth KF, Nehl C, Stierman L (2005) Critical periods of suicide risk in Huntington\u2019s disease. Am J Psychiatry 162:725\u2013731","journal-title":"Am J Psychiatry"},{"key":"9263_CR55","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.jad.2013.06.001","volume":"151","author":"AAM Hubers","year":"2013","unstructured":"Hubers AAM, van Duijn E, Roos RAC, Craufurd D, Rickards H, Bernhard Landwehrmeyer G, van der Mast RC, Giltay EJ (2013) Suicidal ideation in a European Huntington\u2019s disease population. J Affect Disord 151:248\u2013258","journal-title":"J Affect Disord"},{"key":"9263_CR56","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41398-018-0162-2","volume":"8","author":"B Vanle","year":"2018","unstructured":"Vanle B, Olcott W, Jimenez J, Bashmi L, Danovitch I, IsHak WW (2018) NMDA antagonists for treating the non-motor symptoms in Parkinson\u2019s disease. Transl Psychiatry 8:117","journal-title":"Transl Psychiatry"},{"key":"9263_CR57","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2190\/HU6W-3K7Q-NAEL-XU6K","volume":"24","author":"MF Mendez","year":"1994","unstructured":"Mendez MF (1994) Huntington\u2019s disease: update and review of neuropsychiatric aspects. Int J Psychiatry Med 24:189\u2013208","journal-title":"Int J Psychiatry Med"},{"key":"9263_CR58","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1136\/jnnp-2013-307343","volume":"85","author":"E Duijn van","year":"2014","unstructured":"van Duijn E, Craufurd D, Hubers AAM, Giltay EJ, Bonelli R, Rickards H, Anderson KE, van Walsem MR, van der Mast RC, Orth M, Landwehrmeyer GB (2014) Neuropsychiatric symptoms in a European Huntington\u2019s disease cohort (REGISTRY). J Neurol Neurosurg Psychiatry 85:1411\u20131418","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9263_CR59","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2174\/1574886312666170710190820","volume":"12","author":"SL Register","year":"2017","unstructured":"Register SL, Ruano OL, Sanchez DL, Catalano G, Catalano MC (2017) Hallucinations associated with topiramate therapy: a case report and review of the literature. Curr Drug Saf 12:193\u2013197","journal-title":"Curr Drug Saf"},{"key":"9263_CR60","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s40257-016-0219-z","volume":"17","author":"M Nakamura","year":"2016","unstructured":"Nakamura M, Koo J (2016) Drug-induced tactile hallucinations beyond recreational drugs. Am J Clin Dermatol 17:643\u2013652","journal-title":"Am J Clin Dermatol"},{"key":"9263_CR61","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1017\/S0033291712002541","volume":"43","author":"KMJ Diederen","year":"2013","unstructured":"Diederen KMJ, Neggers SFW, de Weijer AD, van Lutterveld R, Daalman K, Eickhoff SB, Clos M, Kahn RS, Sommer IEC (2013) Aberrant resting-state connectivity in non-psychotic individuals with auditory hallucinations. Psychol Med 43:1685\u20131696","journal-title":"Psychol Med"},{"key":"9263_CR62","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1192\/bjp.116.532.255","volume":"116","author":"K Dewhurst","year":"1970","unstructured":"Dewhurst K, Oliver JE, McKnight AL (1970) Socio-psychiatric consequences of Huntington\u2019s disease. Br J Psychiatry 116:255\u2013258","journal-title":"Br J Psychiatry"},{"key":"9263_CR63","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1176\/jnp.6.2.147","volume":"6","author":"JP Fedoroff","year":"1994","unstructured":"Fedoroff JP, Peyser C, Franz ML, Folstein SE (1994) Sexual disorders in Huntington\u2019s disease. J Neuropsychiatry Clin Neurosci 6:147\u2013153","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"9263_CR64","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/B978-0-444-63247-0.00018-3","volume":"130","author":"E Reininghaus","year":"2015","unstructured":"Reininghaus E, Lackner N (2015) Relationship satisfaction and sexuality in Huntington\u2019s disease. Handb Clin Neurol 130:325\u2013334","journal-title":"Handb Clin Neurol"},{"key":"9263_CR65","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3233\/JHD-160224","volume":"6","author":"M Kolenc","year":"2017","unstructured":"Kolenc M, Kobal J, Podnar S (2017) Female sexual dysfunction in presymptomatic mutation carriers and patients with Huntington\u2019s disease. J Huntingtons Dis 6:105\u2013113","journal-title":"J Huntingtons Dis"},{"key":"9263_CR66","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1001\/archneur.56.10.1248","volume":"56","author":"KR Sharma","year":"1999","unstructured":"Sharma KR, Romano JG, Ayyar DR, Rotta FT, Facca A, Sanchez-Ramos J (1999) Sympathetic skin response and heart rate variability in patients with Huntington disease. Arch Neurol 56:1248\u20131252","journal-title":"Arch Neurol"},{"key":"9263_CR67","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/S1474-4422(09)70178-4","volume":"8","author":"JMM Burg van der","year":"2009","unstructured":"van der Burg JMM, Bj\u00f6rkqvist M, Brundin P (2009) Beyond the brain: widespread pathology in Huntington\u2019s disease. Lancet Neurol 8:765\u2013774","journal-title":"Lancet Neurol"},{"key":"9263_CR68","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1002\/mds.22003","volume":"23","author":"YAM Grimbergen","year":"2008","unstructured":"Grimbergen YAM, Knol MJ, Bloem BR, Kremer BPH, Roos RAC, Munneke M (2008) Falls and gait disturbances in Huntington\u2019s disease. Mov Disord 23:970\u2013976","journal-title":"Mov Disord"},{"key":"9263_CR69","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2165\/00002018-199717020-00003","volume":"17","author":"I Verhaeverbeke","year":"1997","unstructured":"Verhaeverbeke I, Mets T (1997) Drug-induced orthostatic hypotension in the elderly: avoiding its onset. Drug Saf 17:105\u2013118","journal-title":"Drug Saf"},{"key":"9263_CR70","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1212\/WNL.35.11.1672","volume":"35","author":"P Hansotia","year":"1985","unstructured":"Hansotia P, Wall R, Berendes J (1985) Sleep disturbances and severity of Huntington\u2019s disease. Neurology 35:1672\u20131674","journal-title":"Neurology"},{"key":"9263_CR71","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1001\/archneur.65.4.482","volume":"65","author":"I Arnulf","year":"2008","unstructured":"Arnulf I, Nielsen J, Lohmann E, Schiefer J, Wild E, Jennum P, Konofal E, Walker M, Oudiette D, Tabrizi S, Durr A (2008) Rapid eye movement sleep disturbances in Huntington disease. Arch Neurol 65:482\u2013488","journal-title":"Arch Neurol"},{"key":"9263_CR72","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/0987-7053(96)81034-3","volume":"25","author":"R Silvestri","year":"1995","unstructured":"Silvestri R, Raffaele M, De Domenico P, Tisano A, Mento G, Casella C, Tripoli MC, Serra S, Di Perri R (1995) Sleep features in Tourette\u2019s syndrome, neuroacanthocytosis and Huntington\u2019s chorea. Neurophysiol Clin Neurophysiol 25:66\u201377","journal-title":"Neurophysiol Clin Neurophysiol"},{"key":"9263_CR73","first-page":"ecurrents","volume":"8","author":"E Varda","year":"2016","unstructured":"Varda E, Demetriou CA, Heraclides A, Christou YP, Zamba-Papanicolaou E (2016) Quality of life of Cypriot patients suffering with Huntington\u2019s disease. PLoS Curr 8:ecurrents","journal-title":"PLoS Curr"},{"key":"9263_CR74","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.jpainsymman.2017.09.004","volume":"55","author":"MO Johnson","year":"2018","unstructured":"Johnson MO, Frank S, Mendlik M, Casarett D (2018) Utilization of hospice services in a population of patients with Huntington\u2019s disease. J Pain Symptom Manage 55:440\u2013443","journal-title":"J Pain Symptom Manage"},{"key":"9263_CR75","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/mds.870110509","volume":"11","author":"MA Nance","year":"1996","unstructured":"Nance MA, Sanders G (1996) Characteristics of individuals with Huntington disease in long-term care. Mov Disord 11:542\u2013548","journal-title":"Mov Disord"},{"key":"9263_CR76","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1001\/archneur.1991.00530200036015","volume":"48","author":"RH Myers","year":"1991","unstructured":"Myers RH, Sax DS, Koroshetz WJ, Mastromauro C, Cupples LA, Kiely DK, Pettengill FK, Bird ED (1991) Factors associated with slow progression in Huntington\u2019s disease. Arch Neurol 48:800\u2013804","journal-title":"Arch Neurol"},{"key":"9263_CR77","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1530\/eje.0.1510451","volume":"151","author":"V Popovic","year":"2004","unstructured":"Popovic V, Svetel M, Djurovic M, Petrovic S, Doknic M, Pekic S, Miljic D, Milic N, Glodic J, Dieguez C, Casanueva FF, Kostic V (2004) Circulating and cerebrospinal fluid ghrelin and leptin: potential role in altered body weight in Huntington\u2019s disease. Eur J Endocrinol 151:451\u2013455","journal-title":"Eur J Endocrinol"},{"key":"9263_CR78","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1212\/01.wnl.0000334276.09729.0e","volume":"71","author":"NA Aziz","year":"2008","unstructured":"Aziz NA, van der Burg JMM, Landwehrmeyer GB, Brundin P, Stijnen T, Roos RAC (2008) Weight loss in Huntington disease increases with higher CAG repeat number. Neurology 71:1506\u20131513","journal-title":"Neurology"},{"key":"9263_CR79","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1212\/01.WNL.0000086373.32347.16","volume":"61","author":"N Mahant","year":"2003","unstructured":"Mahant N, McCusker EA, Byth K, Graham S (2003) Huntington\u2019s disease: clinical correlates of disability and progression. Neurology 61:1085\u20131092","journal-title":"Neurology"},{"key":"9263_CR80","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.expneurol.2007.12.026","volume":"210","author":"AOG Goodman","year":"2008","unstructured":"Goodman AOG, Murgatroyd PR, Medina-Gomez G, Wood NI, Finer N, Vidal-Puig AJ, Morton AJ, Barker RA (2008) The metabolic profile of early Huntington\u2019s disease\u2014a combined human and transgenic mouse study. Exp Neurol 210:691\u2013698","journal-title":"Exp Neurol"},{"key":"9263_CR81","doi-asserted-by":"publisher","first-page":"e4962","DOI":"10.1371\/journal.pone.0004962","volume":"4","author":"N Saleh","year":"2009","unstructured":"Saleh N, Moutereau S, Durr A, Krystkowiak P, Azulay J-P, Tranchant C, Broussolle E, Morin F, Bachoud-Levi A-C, Maison P (2009) Neuroendocrine disturbances in Huntington\u2019s disease. PLoS One 4:e4962","journal-title":"PLoS One"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09263-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-019-09263-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09263-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T04:43:24Z","timestamp":1694666604000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-019-09263-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,5]]},"references-count":81,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["9263"],"URL":"https:\/\/doi.org\/10.1007\/s00415-019-09263-7","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,5]]},"assertion":[{"value":"15 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The authors state that this study has been approved by the ethic committee of Hospital Clinic of Barcelona and have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}